Cytosorbents (CTSO) Cash from Operations (2010 - 2026)
Cytosorbents' (CTSO) quarterly Cash from Operations came in at 1162000.0 in Q1 2026, up 66.47% YoY from 698005.55 in Q1 2025, and up 75.92% on a QoQ basis from 4825000.0 in Q4 2025.
Cytosorbents (CTSO) Cash from Operations (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Cash from Operations data on file, last reported at 1162000.0 in Q1 2026.
- Quarterly Cash from Operations rose 66.47% year-over-year to 1162000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10073000.0 (up 22.9% YoY) and the FY2025 annual result came in at 12377000.0, up 14.22% from the prior year.
- Cash from Operations climbed to 1162000.0 in Q1 2026, from 4825000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1162000.0 in Q1 2026 to a low of 8119170.0 in Q1 2022.
- A 5-year average of 4579789.29 and a median of 4825000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 294.84% — and 2025, when it surged 68.52%.
- Tracing CTSO's Cash from Operations over 5 years: stood at 5340327.0 in 2022, then retreated by 19.98% to 6407411.0 in 2023, then soared by 63.46% to 2341000.0 in 2024, then plunged by 106.11% to 4825000.0 in 2025, then surged by 75.92% to 1162000.0 in 2026.
- The last three Cash from Operations figures came in at 1162000.0 (Q1 2026), 4825000.0 (Q4 2025), and 2577000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Cytosorbents | 21.57 Mn | 17.16 Mn | 7.05 Mn | -583,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -583,000.00 |
| Jun 30, 2026 | -583,000.00 |
| Mar 31, 2026 | -1.16 Mn |
| Mar 31, 2026 | -1.16 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -4.79 Mn |
| Mar 31, 2024 | -4.83 Mn |
| Mar 31, 2024 | -4.83 Mn |